ArticleACS medicinal chemistry letters2023

Discovery of OICR12694: A Novel, Potent, Selective, and Orally Bioavailable BCL6 BTB Inhibitor.

Ahmed Mamai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.